The groundbreaking clinical trial of GDNF, a potential treatment for Parkinson's, is now complete. Analysis of the results is now well underway and is expected to be published in February 2019.

Parkinson's UK announces partnership with the Insight Into Parkinson's summit 2019.

Launching on World Parkinson's Day is attention-grabbing marketing campaign 'Parkinson's Is'. Wesley Vernon shares how people affected by Parkinson's have shaped the campaign.

Broadcaster Claire McCollum calls for people to get involved in events at Lagan Towpath and Antrim Castle.

An update on PIP awards

A clinical trial has produced further evidence that there is no benefit of delaying levodopa therapy.

We’re investing a further £1.5million to advance pioneering drug discovery work to develop new molecules that can both improve symptoms and slow progression.

An update on what's in place to make sure people get their medication in the event of a no deal Brexit.

A refreshed membership offer, updated values, and the launch of 'Parkinson's Is' - Steve Ford, Parkinson's UK Chief Executive, sets out plans for 2019.

Anna Carapellotti and researchers from the School of Psychology at Queen's University Belfast (QUB) are conducting a study evaluating the immediate effects of dance in people with Parkinson's.